|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006611,
umls-concept:C0007120,
umls-concept:C0030705,
umls-concept:C0205250,
umls-concept:C0596545,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2698872,
umls-concept:C2911692,
umls-concept:C2916831
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-12-28
|
|
pubmed:abstractText |
Bronchioloalveolar carcinoma (BAC) is a histological subtype of non-small cell lung cancer (NSCLC), particularly of adenocarcinoma. Given its multifocality and the poor activity of chemotherapy, there is no established treatment for BAC, although promising results have been achieved with inhibitors of the epidermal growth factor receptor (EGFR). No tumor marker has been validated in the diagnosis and follow-up of lung cancer, in particular to predict the outcome of treatment with EGFR inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0393-6155
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-11
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18161663-Adenocarcinoma, Bronchiolo-Alveolar,
pubmed-meshheading:18161663-Adult,
pubmed-meshheading:18161663-Aged,
pubmed-meshheading:18161663-Aged, 80 and over,
pubmed-meshheading:18161663-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18161663-Female,
pubmed-meshheading:18161663-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18161663-Genetic Predisposition to Disease,
pubmed-meshheading:18161663-Humans,
pubmed-meshheading:18161663-Lung Neoplasms,
pubmed-meshheading:18161663-Male,
pubmed-meshheading:18161663-Middle Aged,
pubmed-meshheading:18161663-Mucin-1,
pubmed-meshheading:18161663-Receptor, Epidermal Growth Factor,
pubmed-meshheading:18161663-Tumor Markers, Biological
|
|
pubmed:articleTitle |
MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients.
|
|
pubmed:affiliation |
Division of Medical Oncology A, National Cancer Institute, Aviano, Pordenone, Italy. abearz@cro.it
|
|
pubmed:publicationType |
Journal Article
|
